Sargent Bickham Lagudis’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.15K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $9K | Hold |
|
|||||
|
2021
Q4 | $11K | Hold |
|
|||||
|
2021
Q3 | $13K | Hold |
|
|||||
|
2021
Q2 | $14K | Hold |
|
|||||
|
2021
Q1 | $14K | Hold |
|
|||||
|
2020
Q4 | $14K | Buy |
|
|||||
|
2020
Q3 | $9K | Buy |
|
|||||
|
2020
Q2 | $7K | Buy |
|
|||||
|
2020
Q1 | $3K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $158K | Hold |
|
|||||
|
2018
Q2 | $157K | Hold |
|
|||||
|
2018
Q1 | $144K | Hold |
|
|||||
|
2017
Q4 | $140K | Hold |
|
|||||
|
2017
Q3 | $143K | Hold |
|
|||||
|
2017
Q2 | $127K | Hold |
|
|||||
|
2017
Q1 | $114K | Hold |
|
|||||
|
2016
Q4 | $97K | Hold |
|
|||||
|
2016
Q3 | $109 | Hold |
|
|||||
|
2016
Q2 | $89K | Hold |
|
|||||
|
2016
Q1 | $85K | Buy |
|